Interestingly, in clinical studies, sclerostin levels were shown to be increased in T2DM,13–15 positively correlated with glycated hemoglobin (HbA1c), and inversely associated with bone formation markers. This evidence concerns the gene SOST and type 2 diabetes mellitus.